In contrast, MetS (p = 0.022) and PD-L1 (p = 0.001) expression were associated with lower risks and prior use of broad-spectrum antimicrobials (p = 0.035) a higher risk for overall survival (Figure 1B). This evidence concerns the gene CD274 and metabolic syndrome.